Tirzepatide 5mg

Tirzepatide (Tirze) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. This innovative peptide represents a breakthrough in metabolic therapy, offering superior weight loss and glycemic control compared to single-target approaches. Tirze works by activating both GIP and GLP-1 receptors, leading to enhanced insulin sensitivity, reduced appetite, delayed gastric emptying, and significant weight reduction. Clinical studies have shown remarkable efficacy in both weight management and metabolic health improvement.